NO893193D0 - PEPTIDES WITH BRADYKININE ANTAGONISTIC EFFECT. - Google Patents

PEPTIDES WITH BRADYKININE ANTAGONISTIC EFFECT.

Info

Publication number
NO893193D0
NO893193D0 NO893193A NO893193A NO893193D0 NO 893193 D0 NO893193 D0 NO 893193D0 NO 893193 A NO893193 A NO 893193A NO 893193 A NO893193 A NO 893193A NO 893193 D0 NO893193 D0 NO 893193D0
Authority
NO
Norway
Prior art keywords
amino acid
peptides
bradykinin
direct bond
optionally
Prior art date
Application number
NO893193A
Other languages
Norwegian (no)
Other versions
NO893193L (en
NO177597C (en
NO177597B (en
Inventor
Stephan Henke
Hiristo Anagnostopulos
Gerhard Breipohl
Jochen Knolle
Jens Stechl
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO893193D0 publication Critical patent/NO893193D0/en
Publication of NO893193L publication Critical patent/NO893193L/en
Publication of NO177597B publication Critical patent/NO177597B/en
Publication of NO177597C publication Critical patent/NO177597C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I> in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aromatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or optionally a direct bond, I is -OH, -NH2 or -NHC2H5 and K is a radical -NH(CH2)-1-4-CO- or is a direct bond, have bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are promoted, induced or sustained by bradykinin and bradykinin- related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
NO893193A 1988-11-24 1989-08-08 Analogous Process for Preparing a Therapeutically Active Peptide with Bradykinin Antagonistic Effect NO177597C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3839581 1988-11-24
DE3916291 1989-05-19
DE3918225 1989-06-03

Publications (4)

Publication Number Publication Date
NO893193D0 true NO893193D0 (en) 1989-08-08
NO893193L NO893193L (en) 1990-05-25
NO177597B NO177597B (en) 1995-07-10
NO177597C NO177597C (en) 1995-10-18

Family

ID=27198531

Family Applications (2)

Application Number Title Priority Date Filing Date
NO893193A NO177597C (en) 1988-11-24 1989-08-08 Analogous Process for Preparing a Therapeutically Active Peptide with Bradykinin Antagonistic Effect
NO2008016C NO2008016I2 (en) 1988-11-24 2008-10-30 icatibant

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2008016C NO2008016I2 (en) 1988-11-24 2008-10-30 icatibant

Country Status (26)

Country Link
EP (1) EP0370453B1 (en)
JP (1) JPH07121956B2 (en)
KR (1) KR0139632B1 (en)
CN (1) CN1035006C (en)
AT (1) ATE107318T1 (en)
AU (1) AU612054B2 (en)
CA (1) CA1340667C (en)
CY (2) CY2028A (en)
CZ (1) CZ282384B6 (en)
DE (3) DE58907889D1 (en)
DK (1) DK175344B1 (en)
ES (1) ES2057071T3 (en)
FI (1) FI94353C (en)
HK (1) HK1006716A1 (en)
HU (2) HU210566B (en)
IE (1) IE63490B1 (en)
IL (1) IL91298A (en)
LU (1) LU91499I2 (en)
LV (1) LV10720B (en)
MX (1) MX9203277A (en)
NL (1) NL300359I2 (en)
NO (2) NO177597C (en)
NZ (1) NZ230244A (en)
PH (1) PH31009A (en)
PT (1) PT91692B (en)
SK (1) SK490689A3 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648333A (en) * 1988-11-24 1997-07-15 Hoechst Aktiengesellschaft Peptides having bradykinin antagonist action
DE4013270A1 (en) * 1990-04-26 1991-10-31 Hoechst Ag PEPTIDES WITH BRADYKININ ANTAGONISTIC EFFECT
WO1991009055A1 (en) * 1989-12-08 1991-06-27 Boston University Acylated bradykinin antagonists and uses therefor
MX9100717A (en) * 1990-08-24 1992-04-01 Syntex Inc BRADIQUININE ANTAGONISTS
US5843900A (en) * 1991-04-01 1998-12-01 Cortech, Inc. Bradykinin antagonists
US5416191A (en) * 1991-04-01 1995-05-16 Cortech, Inc. Bradykinin antagonists
AU1914592A (en) * 1991-04-19 1992-11-17 Nova Technology Limited Partnership Bradykinin type peptides
ATE202708T1 (en) * 1991-04-19 2001-07-15 Scios Nova Inc PEPTIDE ANTAGONISTS OF BRADYKININ
US6770741B1 (en) 1991-04-19 2004-08-03 Scios Inc. Bradykinin antagonist peptides
EP0529499A1 (en) * 1991-08-22 1993-03-03 Hoechst Aktiengesellschaft Compositions for topical administration to the nose or the eyes containing bradykinin antagonists
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
TW199863B (en) * 1991-12-21 1993-02-11 Hoechst Ag
WO1993017701A1 (en) * 1992-03-12 1993-09-16 The Administrators Of The Tulane Educational Fund Endothelin receptor-binding peptides
TW258739B (en) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (en) * 1992-06-18 1994-08-19 Adir New peptide derivatives with bradykinin antagonist activity, their preparation process and the pharmaceutical compositions containing them.
US5610142A (en) * 1992-10-08 1997-03-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
US5541286A (en) * 1992-10-08 1996-07-30 Scios Nova Inc. Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
US5686565A (en) * 1992-10-08 1997-11-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
US5817756A (en) * 1993-09-09 1998-10-06 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (en) * 1993-12-31 1995-07-13 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment of viral diseases
CN1150206C (en) * 1994-03-09 2004-05-19 科特克公司 Bradykinin antagonist peptides incorporating N-substituted glycines
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US6407059B1 (en) 1994-06-08 2002-06-18 Peptor Limited Conformationally constrained backbone cyclized peptide analogs
WO1996039425A2 (en) * 1995-06-05 1996-12-12 Cortech, Inc. Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
FR2737408B1 (en) * 1995-07-31 1997-09-05 Oreal USE OF A BRADYKININE ANTAGONIST IN A COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITION AND COMPOSITION OBTAINED
US5849863A (en) * 1995-09-08 1998-12-15 University Of Colorado Cytolytic bradykinin antagonists
US5834431A (en) * 1995-09-08 1998-11-10 Cortech, Inc. Des-Arg9 -BK antagonists
FR2739553B1 (en) * 1995-10-06 1998-01-02 Oreal USE OF BRADYKININE ANTAGONISTS TO STIMULATE OR INDUCE HAIR GROWTH AND / OR STOP THE HAIR LOSS
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
DE19612067A1 (en) * 1996-03-27 1997-10-02 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment of chronic fibrogenetic liver diseases and acute liver diseases
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
DE19642289A1 (en) * 1996-10-14 1998-04-16 Hoechst Ag Use of bradykinin antagonists for the manufacture of medicaments for the treatment and prevention of Alzheimer's disease
DE10304994A1 (en) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh The use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
CN102532267B (en) * 2012-02-09 2014-06-18 深圳翰宇药业股份有限公司 Method for preparing icatibant
CN104043101B (en) * 2014-05-23 2016-04-20 杭州阿德莱诺泰制药技术有限公司 A kind of icatibant composition for injection and preparation method thereof and preparation
KR102099509B1 (en) 2018-07-27 2020-04-09 강경순 Supports for fruit trees
CN111944016B (en) * 2020-08-25 2022-04-29 台州吉诺生物科技有限公司 Preparation method of icatibant acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3044236A1 (en) * 1980-11-25 1982-06-16 Hoechst Ag, 6000 Frankfurt AMINO ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
FR2487829A2 (en) * 1979-12-07 1982-02-05 Science Union & Cie NOVEL SUBSTITUTED IMINO ACIDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
DE3227055A1 (en) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt NEW DERIVATIVES OF 2-AZA-BICYCLO (2.2.2) OCTAN-3-CARBONIC ACID, METHOD FOR THE PRODUCTION THEREOF, THEIR SUBSTANCES AND THE USE THEREOF, AND 2-AZA-BICYCLO (2.2.2) OCTAN-3-CARBONIC ACID AS ANSWER FOR THEIR PRODUCTION
FR2575753B1 (en) * 1985-01-07 1987-02-20 Adir NOVEL PEPTIDE DERIVATIVES WITH NITROGEN POLYCYCLIC STRUCTURE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides

Also Published As

Publication number Publication date
SK279315B6 (en) 1998-09-09
DE122008000066I2 (en) 2009-11-05
EP0370453B1 (en) 1994-06-15
SK490689A3 (en) 1998-09-09
NO893193L (en) 1990-05-25
EP0370453A2 (en) 1990-05-30
KR900007870A (en) 1990-06-02
DK175344B1 (en) 2004-08-30
NO2008016I2 (en) 2012-10-01
AU3943189A (en) 1990-05-31
DK384089A (en) 1990-05-25
FI94353B (en) 1995-05-15
NO177597C (en) 1995-10-18
NO2008016I1 (en) 2008-11-17
EP0370453A3 (en) 1991-12-04
FI893738A0 (en) 1989-08-08
DE3938751A1 (en) 1990-05-31
CA1340667C (en) 1999-07-20
PT91692B (en) 1995-05-31
NL300359I2 (en) 2009-02-02
ATE107318T1 (en) 1994-07-15
IE63490B1 (en) 1995-05-03
HK1006716A1 (en) 1999-03-12
JPH07121956B2 (en) 1995-12-25
HUT52527A (en) 1990-07-28
CZ490689A3 (en) 1997-03-12
IL91298A0 (en) 1990-03-19
HU210712A9 (en) 1995-06-28
LU91499I2 (en) 2009-01-19
CY2008022I2 (en) 2009-11-04
LV10720B (en) 1996-02-20
JPH02184697A (en) 1990-07-19
PH31009A (en) 1997-12-23
CZ282384B6 (en) 1997-07-16
IE892522L (en) 1990-05-24
FI893738A (en) 1990-05-25
FI94353C (en) 1995-08-25
NL300359I1 (en) 2008-11-03
AU612054B2 (en) 1991-06-27
DK384089D0 (en) 1989-08-04
CN1042918A (en) 1990-06-13
NZ230244A (en) 1992-06-25
NO177597B (en) 1995-07-10
CN1035006C (en) 1997-05-28
HU210566B (en) 1995-05-29
ES2057071T3 (en) 1994-10-16
CY2008022I1 (en) 2009-11-04
DE122008000066I1 (en) 2009-05-20
KR0139632B1 (en) 1998-07-01
DE58907889D1 (en) 1994-07-21
LV10720A (en) 1995-06-20
CY2028A (en) 1998-02-20
IL91298A (en) 1994-05-30
MX9203277A (en) 1992-07-01
PT91692A (en) 1990-03-30

Similar Documents

Publication Publication Date Title
NO893193L (en) PEPTIDES WITH BRADYKININE ANTAGONISTIC EFFECT.
NO903545L (en) PEPTIDES WITH BRADYKININE ANTAGONISTIC EFFECT.
DE59108573D1 (en) Peptides with bradykinin antagonistic activity

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: FIRAZYR; NAT. REG. NO/DATE: EU108461001NO 20080825; FIRST REG. NO/DATE: EU , EU108461001 20080711

Spc suppl protection certif: 2008016

Filing date: 20081030

MK1K Patent expired
SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: FIRAZYR; NAT. REG. NO/DATE: EU108461001NO 20080825; FIRST REG. NO/DATE: EU , EU108461001 20080711

Spc suppl protection certif: 2008016

Filing date: 20081030

Extension date: 20140808

Effective date: 20120926

SPCX Expiry of an spc

Spc suppl protection certif: 2008016

Effective date: 20140808